GlucoTrack (GCTK) News Today $0.13 0.00 (-0.23%) Closing price 04:00 PM EasternExtended Trading$0.13 0.00 (-0.75%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period GCTK stock plunges to 52-week low, touches $0.13May 23, 2025 | uk.investing.comGlucotrack Establishes Patient Advisory Board to Inform Diabetes Technology DevelopmentMay 20, 2025 | globenewswire.comGlucoTrack, Inc.: Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 15, 2025 | finanznachrichten.deGlucotrack Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 14, 2025 | globenewswire.comGlucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose MonitorMay 13, 2025 | globenewswire.comGlucoTrack to participate in FORGETDIABETES initiativeApril 17, 2025 | markets.businessinsider.comGlucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic PancreasApril 16, 2025 | globenewswire.comGlucoTrack, OneTwo Analytics collaborate to study analysis on CBG MonitorApril 5, 2025 | markets.businessinsider.comGlucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose MonitorApril 3, 2025 | globenewswire.comGlucotrack Reports Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 31, 2025 | globenewswire.comGlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTDMarch 21, 2025 | markets.businessinsider.comImplantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes CareMarch 19, 2025 | theglobeandmail.comGlucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for DiabetesMarch 19, 2025 | globenewswire.comGlucotrack finalizes equity securities salesMarch 15, 2025 | investing.comGlucotrack appoints Umpierrez to Medical Advisory BoardFebruary 26, 2025 | markets.businessinsider.comGlucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board MemberFebruary 26, 2025 | globenewswire.comEQS-News: Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical TrialFebruary 25, 2025 | markets.businessinsider.comGlucoTrack prices offering of 2.6M shares of common stock at $1.15February 5, 2025 | markets.businessinsider.comGlucotrack sets terms for $3 million public stock offeringFebruary 5, 2025 | msn.comGlucotrack soars on completion of first human clinical study of continuous blood glucose monitorFebruary 5, 2025 | msn.comGlucotrack, Inc. Announces Pricing of $3.0 Million Public OfferingFebruary 4, 2025 | globenewswire.comGlucoTrack announces completion of first in human clinical study of CGMFebruary 4, 2025 | markets.businessinsider.comGlucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose MonitorFebruary 4, 2025 | globenewswire.comGlucoTrack Inc trading halted, news pendingFebruary 4, 2025 | markets.businessinsider.comGCTK Stock Plummets to 52-Week Low of $0.06 Amid Market TurbulenceJanuary 30, 2025 | msn.comGlucotrack Strengthens Leadership Team with Appointment of New Chief Financial OfficerJanuary 29, 2025 | globenewswire.comGlucotrack Announces ISO 13485:2016 CertificationJanuary 21, 2025 | globenewswire.comGlucoTrack (NASDAQ: IGAP)January 16, 2025 | fool.comGlucoTrack appoints Ted Williams as VP, regulatory affairsJanuary 16, 2025 | markets.businessinsider.comGlucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory AffairsJanuary 15, 2025 | globenewswire.comGlucotrack to Present at TechBio Showcase™ 2025January 7, 2025 | globenewswire.comGlucoTrack announces start of enrollment for human clinical study of CBGMDecember 3, 2024 | markets.businessinsider.comGLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITORDecember 3, 2024 | globenewswire.comGlucoTrack Completes Funding to Enhance Financial StabilityNovember 16, 2024 | markets.businessinsider.comGlucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding DebtNovember 14, 2024 | globenewswire.comUnited States shares mixed at close of trade; Dow Jones Industrial Average up 0.11%November 13, 2024 | msn.comGlucotrack, Inc. Announces Pricing of $10.0 Million Public OfferingNovember 13, 2024 | markets.businessinsider.comSay Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is HereOctober 22, 2024 | msn.comGLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCEOctober 22, 2024 | globenewswire.comGlucoTrack (NASDAQ:GCTK) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comGLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETINGOctober 1, 2024 | globenewswire.comJOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORSSeptember 3, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONSAugust 27, 2024 | finance.yahoo.comGlucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual ConferenceAugust 15, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCEAugust 5, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITORJuly 31, 2024 | finance.yahoo.comGLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORSJune 20, 2024 | globenewswire.comGLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSORJune 13, 2024 | globenewswire.comGLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCEJune 10, 2024 | globenewswire.comGLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITORJune 5, 2024 | globenewswire.com Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address GCTK Media Mentions By Week GCTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GCTK News Sentiment▼0.451.02▲Average Medical News Sentiment GCTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GCTK Articles This Week▼21▲GCTK Articles Average Week Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XAIR News NXL News LFWD News VVOS News ICU News BTCY News DHAI News PAVM News SSKN News POAI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GCTK) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GCTK Stock Free GCTK Stock Alerts